Charles Schwab’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $460K | Buy |
87,650
+7,672
| +10% | +$38.6K | ﹤0.01% | 3252 |
|
|
2026
Q1 | $298K | Sell |
79,978
-7,735
| -9% | -$53.4K | ﹤0.01% | 3243 |
|
|
2025
Q4 | $717K | Buy |
87,713
+26
| +0% | +$192 | ﹤0.01% | 3040 |
|
|
2025
Q3 | $645K | Sell |
87,687
-3
| -0% | -$23 | ﹤0.01% | 3088 |
|
|
2025
Q2 | $712K | Buy |
87,690
+8,195
| +10% | +$55.2K | ﹤0.01% | 3009 |
|
|
2025
Q1 | $560K | Buy |
79,495
+5,068
| +7% | +$31.5K | ﹤0.01% | 3041 |
|
|
2024
Q4 | $553K | Buy |
74,427
+13,922
| +23% | +$88.9K | ﹤0.01% | 3115 |
|
|
2024
Q3 | $298K | Hold |
60,505
| – | – | ﹤0.01% | 3285 |
|
|
2024
Q2 | $310K | Buy |
60,505
+50,078
| +480% | +$297K | ﹤0.01% | 3364 |
|
|
2024
Q1 | $55.4K | Hold |
10,427
| – | – | ﹤0.01% | 3359 |
|
|
2023
Q4 | $64.5K | Hold |
10,427
| – | – | ﹤0.01% | 3383 |
|
|
2023
Q3 | $78.7K | Hold |
10,427
| – | – | ﹤0.01% | 3372 |
|
|
2023
Q2 | $101K | Sell |
10,427
-59,401
| -85% | -$363K | ﹤0.01% | 3351 |
|
|
2023
Q1 | $264K | Hold |
69,828
| – | – | ﹤0.01% | 3116 |
|
|
2022
Q4 | $452K | Buy |
69,828
+1,836
| +3% | +$15.1K | ﹤0.01% | 3026 |
|
|
2022
Q3 | $605K | Buy |
67,992
+1
| +0% | +$10 | ﹤0.01% | 2947 |
|
|
2022
Q2 | $678K | Sell |
67,991
-199
| -0.3% | -$1.97K | ﹤0.01% | 2941 |
|
|
2022
Q1 | $790K | Buy |
68,190
+1,826
| +3% | +$20.3K | ﹤0.01% | 2947 |
|
|
2021
Q4 | $737K | Hold |
66,364
| – | – | ﹤0.01% | 3027 |
|
|
2021
Q3 | $612K | Sell |
66,364
-111,531
| -63% | -$1.21M | ﹤0.01% | 3070 |
|
|
2021
Q2 | $2M | Buy |
177,895
+5,057
| +3% | +$58.3K | ﹤0.01% | 2714 |
|
|
2021
Q1 | $1.83M | Buy |
172,838
+5,174
| +3% | +$58.2K | ﹤0.01% | 2687 |
|
|
2020
Q4 | $1.82M | Sell |
167,664
-3,413
| -2% | -$35.3K | ﹤0.01% | 2611 |
|
|
2020
Q3 | $1.66M | Sell |
171,077
-15,324
| -8% | -$146K | ﹤0.01% | 2556 |
|
|
2020
Q2 | $1.48M | Buy |
186,401
+14,257
| +8% | +$147K | ﹤0.01% | 2522 |
|
|
2020
Q1 | $1.5M | Buy |
172,144
+2,279
| +1% | +$23.7K | ﹤0.01% | 2382 |
|
|
2019
Q4 | $1.92M | Buy |
169,865
+5,863
| +4% | +$62.4K | ﹤0.01% | 2433 |
|
|
2019
Q3 | $1.78M | Buy |
164,002
+4,486
| +3% | +$48.8K | ﹤0.01% | 2419 |
|
|
2019
Q2 | $1.5M | Buy |
159,516
+4,760
| +3% | +$48K | ﹤0.01% | 2456 |
|
|
2019
Q1 | $1.9M | Buy |
154,756
+2,766
| +2% | +$33.8K | ﹤0.01% | 2377 |
|
|
2018
Q4 | $1.8M | Buy |
151,990
+960
| +0.6% | +$13.2K | ﹤0.01% | 2367 |
|
|
2018
Q3 | $2.17M | Buy |
151,030
+7,305
| +5% | +$101K | ﹤0.01% | 2404 |
|
|
2018
Q2 | $2.14M | Buy |
143,725
+22,475
| +19% | +$312K | ﹤0.01% | 2356 |
|
|
2018
Q1 | $1.58M | Buy |
121,250
+3,861
| +3% | +$50.7K | ﹤0.01% | 2403 |
|
|
2017
Q4 | $1.48M | Buy |
117,389
+5,148
| +5% | +$65.1K | ﹤0.01% | 2405 |
|
|
2017
Q3 | $1.45M | Buy |
112,241
+5,432
| +5% | +$71.6K | ﹤0.01% | 2403 |
|
|
2017
Q2 | $1.59M | Buy |
106,809
+589
| +0.6% | +$8.2K | ﹤0.01% | 2300 |
|
|
2017
Q1 | $1.27M | Buy |
106,220
+5,301
| +5% | +$67.1K | ﹤0.01% | 2353 |
|
|
2016
Q4 | $1.39M | Buy |
100,919
+4,774
| +5% | +$66.1K | ﹤0.01% | 2317 |
|
|
2016
Q3 | $1.29M | Buy |
96,145
+4,090
| +4% | +$49.5K | ﹤0.01% | 2323 |
|
|
2016
Q2 | $991K | Sell |
92,055
-19,784
| -18% | -$218K | ﹤0.01% | 2347 |
|
|
2016
Q1 | $1.18M | Buy |
111,839
+2,474
| +2% | +$27.2K | ﹤0.01% | 2275 |
|
|
2015
Q4 | $1.29M | Buy |
109,365
+3,702
| +4% | +$45.5K | ﹤0.01% | 2275 |
|
|
2015
Q3 | $1.23M | Buy |
105,663
+23,475
| +29% | +$311K | ﹤0.01% | 2308 |
|
|
2015
Q2 | $1.19M | Buy |
82,188
+2,214
| +3% | +$32K | ﹤0.01% | 2340 |
|
|
2015
Q1 | $1.12M | Buy |
79,974
+3,132
| +4% | +$43.3K | ﹤0.01% | 2327 |
|
|
2014
Q4 | $1.06M | Buy |
76,842
+1,647
| +2% | +$21.3K | ﹤0.01% | 2327 |
|
|
2014
Q3 | $922K | Buy |
75,195
+10,675
| +17% | +$133K | ﹤0.01% | 2336 |
|
|
2014
Q2 | $806K | Sell |
64,520
-416
| -0.6% | -$4.9K | ﹤0.01% | 2417 |
|
|
2014
Q1 | $725K | Buy |
64,936
+1,560
| +2% | +$17.1K | ﹤0.01% | 2435 |
|
|
2013
Q4 | $769K | Buy |
63,376
+1,942
| +3% | +$23.2K | ﹤0.01% | 2399 |
|
|
2013
Q3 | $754K | Buy |
61,434
+10
| +0% | +$140 | ﹤0.01% | 2350 |
|
|
2013
Q2 | $851K | Buy |
+61,424
| New | +$849K | ﹤0.01% | 2254 |
|
Other funds holding LFCR
WC
LPAM
GRIM
3C
QOP
Charles Schwab's LFCR Position: Q2 2026 in Review
Charles Schwab increased its Lifecore Biomedical (LFCR) stake by 9.6% in Q2 2026, buying an estimated $38.6K and bringing the position to 87,650 shares worth $460K. The position accounts for ﹤0.01% of the portfolio, ranked #3252.
Charles Schwab first reported a position in LFCR in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.17M in Q3 2018. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.
- Charles Schwab held 87,650 shares of Lifecore Biomedical worth $460K as of Q2 2026.
- Charles Schwab bought 7,672 Lifecore Biomedical shares in Q2 2026, an estimated $38.6K.
- Lifecore Biomedical made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #3252 holding.
- Charles Schwab first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's Lifecore Biomedical position peaked at $2.17M in Q3 2018.
- 99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.